[3H]Threo‐(±)‐Methylphenidate Binding to 3,4‐Dihydroxyphenylethylamine Uptake Sites in Corpus Striatum: Correlation with the Stimulant Properties of Ritalinic Acid Esters

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Neurochemistry

• Publication date

  1985-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1471-4159.1985.tb05524.xPMID 4031878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.

  1985cited by this paper
• [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

  1984cited by this paper
• Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system.

  1984cited by this paper
• Analyzing nonlinear scatchard plots.

  1984cited by this paper
• Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake Sites

  1983cited by this paper
• [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes.

  1983cited by this paper
• (+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines.

  1982cited by this paper
• ARYL 1,4-DIALK(EN)YLPIPERAZINES AS SELECTIVE AND VERY POTENT INHIBITORS OF DOPAMINE UPTAKE

  1981cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• The central stimulatory action of inhibitors of the dopamine uptake.

  1979cited by this paper
• Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.

  1979cited by this paper
• Amphetamines: Structure-Activity Relationships

  1978cited by this paper
• Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.

  1977cited by this paper
• Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate

  1975cited by this paper
• Blockade by reserpine of methylphenidate-induced release of brain dopamine.

  1975cited by this paper
• Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison.

  1974cited by this paper
• The uptake of (3H)dopamine by homogenates of rat corpus striatum: effects of cations.

  1973cited by this paper
• Diagnosis and Drug Treatment of Psychiatric Disorders

  1969cited by this paper
• The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

  1962cited by this paper
• Relative hydrolytic rates of certain alkyl (b) dl-alpha-(2-piperidyl)-phenylacetates.

  1961cited by this paper
• Relative Hydrolytic Rates of Certain Alkyl (b) dl-α-(2-Piperidyl)-phenylacetates

  1961cited by this paper
• Distribution and elimination of methylphenidate-C14.

  1960cited by this paper
• Protein determination for large numbers of samples.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Methylphenidate as a Novel Adjunct in Opioid-Taking Patients: Insights into Dopaminergic Neuroadaptation and Hypoactive Delirium

  2025cites this paper
• Serotonin-dopamine interactions in psychostimulant-induced gene regulation: SSRI antidepressants potentiate gene regulation by methylphenidate (Ritalin) in the striatum and enhance behavioral profile indicative of addiction liability in rodents.

  2025cites this paper
• THE INFLUENCE OF EARLY EXPOSURE TO METHYLPHENIDATE ON ADDICTION-RELATED BEHAVIORS IN MICE.

  2021cites this paper
• An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations

  2020cites this paper
• Effects of benztropine analogs on delay discounting in rats

  2020cites this paper
• Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies.

  2019cites this paper
• PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics

  2019cites this paper
• Cocaine enhances figural, but impairs verbal 'flexible' divergent thinking.

  2019cites this paper
• The asymmetric synthesis of (S,S)-methylphenidate hydrochloride via ring-opening of an enantiopure aziridinium intermediate with phenylmagnesium bromide

  2019cites this paper
• Novel Psychoactive Drugs

  2019influential citation
• Use of cognitive enhancers: methylphenidate and analogs.

  2019cites this paper
• Effects of taurine on striatal dopamine transporter expression and dopamine uptake in SHR rats

  2018cites this paper
• Catalytic C-H Insertion Reactions

  2018cites this paper
• In Vitro Neurochemical Assessment of Methylphenidate and Its “Legal High” Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis

  2018cites this paper
• A single dose of cocaine enhances prospective memory performance

  2018cites this paper
• The effects of adolescent methylphenidate exposure on the behavioral and brain-derived neurotrophic factor response to nicotine

  2017cites this paper
• Chapter 31 - Psychostimulant-Induced Gene Regulation in Striatal Circuits

  2017cites this paper
• Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters

  2016cites this paper
• Exposure to methylphenidate during peri-adolescence affects endocrine functioning and sexual behavior in female Long-Evans rats.

  2016cites this paper
• An acute, non-therapeutic dose of methylphenidate disrupts partner preference in female rats.

  2016cites this paper
• Effects of Methylphenidate and Atomoxetine on Development of the Brain

  2016cites this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015influential citation
• Repeated methylphenidate administration during lactation reduces maternal behavior, induces maternal tolerance, and increases anxiety-like behavior in pups in adulthood.

  2015cites this paper
• Methylphenidate-induced spontaneous ejaculation

  2015cites this paper
• An Analysis of the Interaction of Methylphenidate and Nicotine in Adolescent Rats: Effects on BDNF

  2015cites this paper
• Methylphenidate Intoxication: Somnolence as an Uncommon Clinical Symptom and Proof of Overdosing by Increased Serum Levels of Ritalinic Acid

  2014cites this paper
• Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.

  2014cites this paper
• Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

  2014cites this paper
• Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats

  2014cites this paper
• Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

  2014cites this paper
• Analysis of the role of D 2 receptors in methylphenidate-induced conditioned place preference

  2014cites this paper
• Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

  2013cites this paper
• Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain – an in vivo study

  2013cites this paper
• Ethylphenidate: From biomarker to designer drug

  2013cites this paper
• Analysis of the role of D2 receptors in methylphenidate-induced conditioned place preference.

  2013cites this paper
• Methylphenidate Conditioned Place Preference in Juvenile and Adolescent Male and Female Rats

  2013cites this paper
• Investigating the effects of methamphetamine on metabolite markers and white matter in the brain

  2013cites this paper
• Dynamic Regulation at the Neuronal Plasma Membrane: Novel Endocytic Mechanisms Control Anesthetic-Activated Potassium Channels and Amphetamine-Sensitive Dopamine Transporters: A Dissertation

  2013cites this paper
• A Mathematical Approach to the Body-Mind Problem from a System Personality Theory (A Systems Approach to the Body-Mind Problem)

  2013cites this paper
• Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor

  2012cites this paper
• Chronic Treatment with Extended Release Methylphenidate Does Not Alter Dopamine Systems or Increase Vulnerability for Cocaine Self-Administration: A Study in Nonhuman Primates

  2012cites this paper
• Intra-individual variability in adult ADHD: an exploration of the viability of distinct purely inattentive condition

  2012cites this paper
• Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats

  2012cites this paper
• The Neuropsychopharmacology of Stimulants: Dopamine and ADHD

  2012cites this paper
• DISCOVERY OF GZ-793A, A NOVEL VMAT2 INHIBITOR AND POTENTIAL PHARMACOTHERAPY FOR METHAMPHETAMINE ABUSE

  2012cites this paper
• Acquisition and Responding for Conditioned Reinforcement in the Mouse: Effects of Methylphenidate, and the Role of the Dopamine Transporter

  2012cites this paper
• Changing the General Factor of Personality and the c-fos Gene Expression with Methylphenidate and Self-Regulation Therapy

  2012cites this paper
• Testing Drosophila learning and memory mutants with and without methylphenidate treatment in Buridan's paradigm

  2012cites this paper
• Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment

  2011cites this paper
• PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES

  2011cites this paper
• Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

  2010cites this paper
• Quantitative structure-activity relationship studies of threo-methylphenidate analogs.

  2010cites this paper
• Psychostimulant-Induced Gene Regulation in Corticostriatal Circuits

  2010cites this paper
• Three point chiral recognition and resolution of amino alcohols through well-defined interaction inside a metallocavity.

  2010cites this paper
• Effect of Acute and Chronic Administration of Methylphenidate on Mitochondrial Respiratory Chain in the Brain of Young Rats

  2010cites this paper
• Handbook of basal ganglia structure and function

  2010cites this paper
• Chronic Administration of Methylphenidate Induces Lipid Peroxidation in the Striatum of Young Rats

  2009cites this paper
• Dose‐Dependent Immunohistochemical Changes in Rat Cornea and Retina after Oral Methylphenidate Administration

  2009cites this paper
• Cocaine Alters Vesicular Dopamine Sequestration and Potassium-Stimulated Dopamine Release: The Role of D2 Receptor Activation

  2009cites this paper
• Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.

  2009cites this paper
• Modafinil reinstates a cocaine conditioned place preference following extinction in rats.

  2009cites this paper
• 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

  2008cites this paper
• Dose-dependent ultrastructural changes in rat cornea after oral methylphenidate administration.

  2008cites this paper
• Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.

  2008cites this paper
• Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?

  2008cites this paper
• Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.

  2008cites this paper
• Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate

  2008cites this paper
• Methylphenidate and cocaine: the same effects on gene regulation?

  2007cites this paper
• Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

  2007cites this paper
• DNA damage in rats after treatment with methylphenidate.

  2007cites this paper
• [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].

  2007cites this paper
• [11C]LBT‐999: A suitable radioligand for investigation of extra‐striatal dopamine transporter with PET

  2007cites this paper
• The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.

  2007cites this paper
• Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a

  2007cites this paper
• Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.

  2007cites this paper
• NEUROCHEMICAL STUDIES OF ATTENTION-DEFIC IT/HYPERA CTIVITY DISORDER MEDICATIONS IN THE STRIATUM AND NUCLEUS ACCUMBENS OF THE FISCHER 344 RA T

  2006cites this paper
• Ligand-based design of dopamine reuptake inhibitors : fuzzy relational clustering and 2-D and 3-D QSAR modleing

  2006cites this paper
• Methylphenidate treatment induces oxidative stress in young rat brain.

  2006cites this paper
• Neuropsychiatrie des Methylphenidat bei der Aufmerksamkeits-Defizit/Hyperaktivitäts-Störung (ADHS)

  2006cites this paper
• Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum

  2005cites this paper
• Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects

  2005cites this paper
• Methylphenidate HCl: therapy for attention deficit hyperactivity disorder

  2005cites this paper
• The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.

  2005cites this paper
• Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.

  2005cites this paper
• Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.

  2005cites this paper
• Topography of Methylphenidate (Ritalin)-Induced Gene Regulation in the Striatum: Differential Effects on c-Fos, Substance P and Opioid Peptides

  2005cites this paper
• New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder

  2005cites this paper
• Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods

  2004cites this paper
• Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood.

  2003cites this paper
• Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935

  2003cites this paper
• Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum

  2003cites this paper
• The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder

  2003cites this paper
• Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate.

  2003cites this paper
• Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.

  2003cites this paper
• Highlights of PET studies on chiral radiotracers and drugs at Brookhaven

  2003cites this paper
• Dopamintransporters im Gehirn bei gesunden Kontrollen, Patienten mit schizophrenen Störungen und Patienten mit Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen

  2003cites this paper
• Palliative uses of methylphenidate in patients with cancer: a review.

  2002cites this paper
• Palliative U ses o f M ethylphenidate i n P atients W ith Cancer: A R eview

  2002cites this paper
• Dopamine transporter‐dependent induction of C‐Fos in HEK cells

  2002cites this paper
• 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat

  2002cites this paper